ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
62.19
+0.84 (1.37%)
At close: Jul 19, 2024, 4:30 PM
62.20
+0.01 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products.
It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals.
ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals, Inc.
Country | United States |
Founded | 2001 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 642 |
CEO | Nikhil Lalwani |
Contact Details
Address: 210 Main Street West Baudette, Minnesota 56623 United States | |
Phone | (218) 634-3500 |
Website | anipharmaceuticals.com |
Stock Details
Ticker Symbol | ANIP |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001023024 |
CUSIP Number | 00182C103 |
ISIN Number | US00182C1036 |
Employer ID | 58-2301143 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Nikhil Lalwani | President, Chief Executive Officer and Director |
Stephen P. Carey | Senior Vice President of Finance and Chief Financial Officer |
Chad Gassert | Senior Vice President of Corporate Development and Strategy |
Christopher K. Mutz | Senior Vp and Head of Rare Disease |
Ori Gutwerg | Senior Vice President of Generics |
Muthusamy Shanmugam MS R.Ph. | Head of Research & Development, Chief Operating Officer of Novitium Operations and Director |
James G. Marken | Senior Vice President of Operations and Product Development |
Meredith W. Cook | Senior Vice President, General Counsel and Corporate Secretary |
Krista L. Davis | Senior Vice President and Chief Human Resources Officer |
Elizabeth Powell J.D. | Chief Compliance Officer and Head of Legal of Rare Disease |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 18, 2024 | 144 | Filing |
Jul 17, 2024 | 144 | Filing |
Jul 16, 2024 | 144 | Filing |
Jul 15, 2024 | 144 | Filing |
Jul 12, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Jun 24, 2024 | 8-K | Current Report |
Jun 21, 2024 | 144 | Filing |
Jun 20, 2024 | 144 | Filing |
Jun 18, 2024 | 144 | Filing |
Jun 17, 2024 | 144 | Filing |